| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.10B | +18.8% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | -57.7% |
| Gross margin | 21.1% | Net margin 4.3% |
| Revenue Q/Q | -9.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 78.9% |
| R&D | ¥0.01B | 7.1% |
| SG&A | ¥0.01B | 10.1% |
| Tax & other | ¥-0.00B | -1.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁 ・ 格力博 ・ 恒工精密 ・ 海看股份 ・ 泰恩康 ・ 华新科技 ・ 宇邦新材 ・ 华厦眼科 ・ 铭利达
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies